Search

everythinglearnresearchcommunity

for

Search:↓

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Pannexin 3 is important for bone formation and the development of bone cells.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

Scientists created a cell model to study and find treatments for a skin disease called RDEB.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

CGF therapy may effectively treat psoriasis by reducing inflammation.

The DiLiCre mouse model is an effective tool for precise genome editing using light.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Circ 0020938 slows down hair growth in cashmere goats.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

LncRNA018392 helps goat skin cells grow by increasing CSF1R.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Dupilumab effectively treated severe alopecia areata in a child.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.